Vaccine-related adverse events following ChAdOx1-nCoV-19 vaccine in actively treated patients with solid malignancy, as compared to age-matched healthy controls.

被引：0

作者：

Pakvisal, Nussara

Sainamthip, Panot

Teeyapun, Nattaya

Luangdilok, Sutima

Wanchaijiraboon, Passakorn

Wanlapakorn, Nasamon

Susiriwatananont, Thiti

Zungsontiporn, Nicha

Sriuranpong, Virote

Poovorawan, Yong

Yorsaeng, Ritthideach

Namkanisorn, Teerayuth

Tanasanvimon, Suebpong

机构：

[1] Chulalongkorn Univ, Div Med Oncol, Dept Med, Bangkok, Thailand

[2] Chulalongkorn Mem Hosp, Bangkok, Thailand

[3] Chulalongkorn Univ, Dept Pharmacol, Fac Med, Bangkok, Thailand

[4] King Chulalongkorn Mem Hosp, Bangkok, Thailand

[5] Chulalongkorn Univ, Fac Med, Devis Med Oncol, Dept Med, Bangkok, Thailand

[6] Chulalongkorn Univ, Dept Biochem, Fac Med, Bangkok, Thailand

[7] Phrapokklao Hosp, Phrapokklao Canc Ctr Excellence, Chanthaburi, Thailand

[8] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok, Thailand

[9] Chulalongkorn Univ, Div Med Oncol, Dept Med, Fac Med, Bangkok, Thailand

[10] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Div Med Oncol, Fac Med, Bangkok, Thailand

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e13517

引用

页数：1

共 17 条

[1] Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls
Pakvisal, Nussara
Sainamthip, Panot
Teeyapun, Nattaya
Luangdilok, Sutima
Wanlapakorn, Nassamon
Yorsaeng, Ritthideach
Poovorawan, Yong
Pakvisal, Piyapoom
Susiriwatananont, Thiti
Zungsontiporn, Nicha
Sriuranpong, Virote
Tanasanvimon, Suebpong
Wanchaijiraboon, Passakorn
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
[2] Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study
Teeyapun, Nattaya
Luangdilok, Sutima
Pakvisal, Nussara
Sainamthip, Panot
Mingmalairak, Siyamol
Poovorawan, Nattaya
Sitthideatphaiboon, Piyada
Parinyanitikul, Napa
Sriuranpong, Virote
Namkanisorn, Teerayuth
Inthasuwan, Pratchaya
Angspatt, Pattama
Wongchanapat, Ploytuangporn
Bamrungnam, Akradach
Leeleakpai, Nutchanok
Uttha, Sutheera
Jaichum, Supaporn
Kongkaew, Peerawich
Suksanong, Chayanin
Veranitinun, Rattiya
Prasomphol, Ampai
Sartsuk, Chada
Patcharajutanon, Cheeraporn
Preaprang, Supreeya
Choengsamor, Hathairat
Phongwan, Rungthong
Preeyasaksa, Charoenpit
Phaibulvatanapong, Ekkamol
Suntronwong, Nungruthai
Yorsaeng, Ritthideach
Vichaiwattana, Preeyaporn
Wanlapakorn, Nasamon
Kerr, Stephen J.
Poovorawan, Yong
Wanchaijiraboon, Passakorn
Tanasanvimon, Suebpong
ECLINICALMEDICINE, 2022, 52
[3] Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study
Teeyapun, Nattaya
Luangdilok, Sutima
Pakvisal, Nussara
Sainamthip, Panot
Mingmalairak, Siyamol
Poovorawan, Nattaya
Sitthideatphaiboon, Piyada
Parinyanitikul, Napa
Sriuranpong, Virote
Namkanisorn, Teerayuth
Inthasuwan, Pratchaya
Angspatt, Pattama
Wongchanapat, Ploytuangporn
Bamrungnam, Akradach
Leeleakpai, Nutchanok
Uttha, Sutheera
Jaichum, Supaporn
Kongkaew, Peerawich
Suksanong, Chayanin
Veranitinun, Rattiya
Prasomphol, Ampai
Sartsuk, Chada
Patcharajutanon, Cheeraporn
Preaprang, Supreeya
Choengsamor, Hathairat
Phongwan, Rungthong
Preeyasaksa, Charoenpit
Phaibulvatanapong, Ekkamol
Suntronwong, Nungruthai
Yorsaeng, Ritthideach
Vichaiwattana, Preeyaporn
Wanlapakorn, Nasamon
Kerr, Stephen J.
Poovorawan, Yong
Wanchaijiraboon, Passakorn
Tanasanvimon, Suebpong
ECLINICALMEDICINE, 2022, 52
[4] Kynurenine-to-tryptophan ratio in solid cancer patients receiving ChAdOx1-nCoV-19 vaccine
Panasawatwong, Bunnatut
Khlaiphayak, Phacharaphon
Morales, Noppawan Phumala
Yamanont, Paveena
Prasomphol, Ampai
Sartsuk, Chada
Preaprang, Supreeya
Choengsamor, Hathairat
Phongwan, Rungthong
Sanvarinda, Pimtip
Wanchaijiraboon, Passakorn
ANNALS OF ONCOLOGY, 2023, 34 : S1429 - S1430
[5] COVID-19 Vaccine-Related Adverse Events in Solid Cancer Patients Treated with Immunotherapy
Bouleftour, Wafa
Bonjean, Paul
Grangeon, Kevin
Magne, Nicolas
CANCER INVESTIGATION, 2022, 40 (09) : 760 - 766
[6] Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment
Wanchaijiraboon, Passakorn
Teeyapun, Nattaya
Pakvisal, Nussara
Sainamthip, Panot
Susiriwatananont, Thiti
Zungsontiporn, Nicha
Suntronwong, Nungruthai
Vichaiwattana, Preeyaporn
Klinsawat, Worata
Wanlapakorn, Nasamon
Tanasanvimon, Suebpong
Sriuranpong, Virote
Poovorawan, Yong
Luangdilok, Sutima
VACCINES, 2022, 10 (10)
[7] Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future
Hamayoun, Mohammad
Abdulrazak, Ibrahim
Farid, Muhammad
Malik, Mamunur Rahman
Farah, Mohammed
IJID REGIONS, 2022, 4 : 47 - 52
[8] Adverse events following immunization associated with the ChAdOx1nCoV-19 and BBV152 vaccine-a cross-sectional study
Prasad, T. S. Durga
Gouru, Guna
Vasuprada, S.
Sandhya, B.
Priya, D. S. Kavi
Sudhakar, T.
INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2023, 13 (03): : P76 - P83
[9] Adverse Events Following Immunization Associated with the First and Second Doses of the ChAdOx1 nCoV-19 Vaccine among Healthcare Workers in Korea
Jeon, Minji
Kim, Jehun
Oh, Chi Eun
Lee, Jin-Young
VACCINES, 2021, 9 (10)
[10] Adverse events following immunization of ChAdOx1 nCoV-19 vaccine among healthcare workers of a medicine-teaching institution of North India
Jha, Abhinav
Kumar, Pankaj
Goel, Shelesh K.
Bharatwal, Apoorv A.
Dhamnetiya, Deepak
Singh, Saurabh
Jha, Ravi P.
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (01) : 298 - 310

← 1 2 →